| scholarly article | Q13442814 |
| P2093 | author name string | Nora Sarvetnick | |
| Peter Gottlieb | |||
| Lynette M Smith | |||
| Kristina M Lorenzo-Arteaga | |||
| Robert Z Harms | |||
| Katie R Ostlund | |||
| Victoria B Smith | |||
| P2860 | cites work | Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes | Q74530044 |
| Increased intestinal permeability precedes clinical onset of type 1 diabetes | Q79211266 | ||
| Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) | Q81152153 | ||
| Type 1 diabetes | Q27000491 | ||
| MAIT cells detect and efficiently lyse bacterially-infected epithelial cells | Q27332162 | ||
| MAIT cells are activated during human viral infections | Q27469032 | ||
| T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents | Q27485358 | ||
| Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells | Q27680179 | ||
| The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4 | Q28239606 | ||
| Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4 | Q28259171 | ||
| Genetic risk factors for type 1 diabetes | Q28276356 | ||
| Environmental risk factors for type 1 diabetes | Q28276366 | ||
| CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
| Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
| Stepwise development of MAIT cells in mouse and human | Q33417043 | ||
| Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression | Q33769360 | ||
| A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. | Q33789317 | ||
| Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans | Q33826540 | ||
| Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. | Q33887115 | ||
| Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes | Q34042503 | ||
| Hygiene hypothesis and autoimmune diseases | Q34233260 | ||
| Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. | Q34244112 | ||
| Molecular mimicry and immune-mediated diseases | Q34474075 | ||
| Human cytomegalovirus: Latency and reactivation in the myeloid lineage | Q34731399 | ||
| MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. | Q34890728 | ||
| Analysis of islet inflammation in human type 1 diabetes. | Q34917032 | ||
| Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. | Q35016866 | ||
| Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics | Q35018923 | ||
| Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young | Q35043330 | ||
| Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging | Q35107330 | ||
| Analysis of the Phenotype and Function of the Subpopulations of Mucosal-Associated Invariant T Cells. | Q50632804 | ||
| Probability state modeling of memory CD8⁺ T-cell differentiation. | Q50886114 | ||
| Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. | Q51030308 | ||
| Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. | Q51994120 | ||
| Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. | Q52012681 | ||
| Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. | Q52319664 | ||
| A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. | Q52628213 | ||
| TNFα and IL-1β in the synovial fluid facilitate mucosal-associated invariant T (MAIT) cell migration. | Q52760712 | ||
| Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes. | Q54560904 | ||
| Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study | Q57449051 | ||
| Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. | Q64977386 | ||
| Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells | Q73250785 | ||
| Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis | Q73959243 | ||
| Susceptibility of human pancreatic β cells for cytomegalovirus infection and the effects on cellular immunogenicity | Q39430309 | ||
| Rules of chemokine receptor association with T cell polarization in vivo | Q39947109 | ||
| Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it? | Q40108816 | ||
| Cytomegalovirus infection in immunocompetent patients | Q40543447 | ||
| HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57. | Q40835211 | ||
| Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease | Q40970092 | ||
| Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis | Q41689680 | ||
| Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus | Q41737589 | ||
| Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals | Q42233193 | ||
| Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes | Q42695808 | ||
| CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood | Q44659046 | ||
| Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population | Q44933069 | ||
| The T cell response to persistent herpes virus infections in common variable immunodeficiency | Q45411294 | ||
| Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections | Q45733084 | ||
| Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. | Q45939390 | ||
| Understanding and preventing type 1 diabetes through the unique working model of TrialNet | Q46486153 | ||
| Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18. | Q47149968 | ||
| Recent Advances in Type-2-Cell-Mediated Immunity: Insights from Helminth Infection. | Q47270730 | ||
| Autoreactive T cells in type 1 diabetes | Q48004838 | ||
| MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A. | Q48223629 | ||
| CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis | Q48648923 | ||
| Development of autoantibodies in the TrialNet Natural History Study | Q35179922 | ||
| β cell death and dysfunction during type 1 diabetes development in at-risk individuals | Q35183950 | ||
| Changes in histone acetylation and methylation that are important for persistent but not transient expression of CCR4 in human CD4+ T cells. | Q35546783 | ||
| The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes | Q35557877 | ||
| Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses | Q35614110 | ||
| CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells | Q35635852 | ||
| Expression and regulation of chemokines in murine and human type 1 diabetes. | Q35696643 | ||
| CD28 extinction in human T cells: altered functions and the program of T-cell senescence | Q36121041 | ||
| CD8+ T cells in autoimmunity | Q36286977 | ||
| MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications | Q36338406 | ||
| Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells | Q36381877 | ||
| Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. | Q36488883 | ||
| The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes | Q36547636 | ||
| Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection | Q36595308 | ||
| Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection | Q36619693 | ||
| Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? | Q36665469 | ||
| CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope | Q36890836 | ||
| Type 1 diabetes as a relapsing-remitting disease? | Q36992950 | ||
| Life and death of β cells in Type 1 diabetes: A comprehensive review | Q36995568 | ||
| Overview of the diagnosis of cytomegalovirus infection | Q37062282 | ||
| The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression | Q37089835 | ||
| Expansion of human regulatory T-cells from patients with type 1 diabetes | Q37105331 | ||
| Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation | Q37247617 | ||
| Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. | Q37276644 | ||
| Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future | Q37364899 | ||
| Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development | Q37564579 | ||
| Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? | Q37783109 | ||
| Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces | Q37804993 | ||
| CD8(+) T cells: foot soldiers of the immune system | Q37922333 | ||
| The who's who of T-cell differentiation: human memory T-cell subsets | Q38164599 | ||
| Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. | Q38319280 | ||
| Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota | Q38742211 | ||
| Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. | Q38840445 | ||
| Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cells | Q39039728 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| type-1 diabetes | Q124407 | ||
| P304 | page(s) | 2332 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes | |
| P478 | volume | 9 |
Search more.